Announced details
Influenza diagnosis and disease severity, health and lifestyle habits, infection history in the previous season, household composition, diagnoses within the household
Influenza diagnosis incidence rate of 10.91% in the 2024-2025 season. Hospitalization was 1.76 times higher among antihypertensive drug users than non-users, while severe hospitalization, including ICU admission, was 2.88 times higher. The household transmission rate was 51.4% in households of 5 or more people.
JMDC and Sumitomo Life Insurance Company jointly published the report. The research and analysis used healthcare big data held by JMDC. No capital or personnel relationship is stated.
Headquarters: Osaka City, Osaka Prefecture. Representative Director, President and Representative Executive Officer: Takada Yukinori (高田幸徳). The Sumitomo Life Group provides insurance products and services and operates a Well-being as a Service (WaaS) business.
Healthcare big data covering approximately 10 million people
No information was provided regarding the impact on financial results.
The company does not address Contract Value / Offering price.
Healthcare big data held by JMDC. Full report URL: https://www.jmdc.co.jp/terms/influenza_report_202611.pdf
| Item | Details |
|---|---|
| Names of Products / Services Covered | Influenza Real-World Data Report 2026 |
| Counterparty | Sumitomo Life Insurance Company |
| Counterparty overview | Headquarters: Osaka City, Osaka Prefecture. Representative Director, President and Representative Executive Officer: Takada Yukinori (高田幸徳). The Sumitomo Life Group provides insurance products and services and operates a Well-being as a Service (WaaS) business. |
| Relationship with the Company | JMDC and Sumitomo Life Insurance Company jointly published the report. The research and analysis used healthcare big data held by JMDC. No capital or personnel relationship is stated. |
| Launch date | 4 November 2026 (published) |
| Applicable area | Influenza diagnosis and disease severity, health and lifestyle habits, infection history in the previous season, household composition, diagnoses within the household |
| Location scale | Healthcare big data covering approximately 10 million people |
| Quantitative Effects | Influenza diagnosis incidence rate of 10.91% in the 2024-2025 season. Hospitalization was 1.76 times higher among antihypertensive drug users than non-users, while severe hospitalization, including ICU admission, was 2.88 times higher. The household transmission rate was 51.4% in households of 5 or more people. |
| Impact on Business Performance | No information was provided regarding the impact on financial results. |
| Source | Healthcare big data held by JMDC. Full report URL: https://www.jmdc.co.jp/terms/influenza_report_202611.pdf |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide evidence on influenza diagnosis and the risk of severe disease, diagnosis history and the realities of household transmission. The initiative also seeks to address social issues through data and ICT and promote the practical implementation of data in society.